Summary
Subjects aged 3–6, 16–17 and 27–50 years were vaccinated with one dose of hemagglutinin influenza virus vaccine. Clinical reactions, hemagglutination-inhibiting (HI) and strain- and type-specific complement-fixing (CF-V and CF-S) antibodies were determined in sera taken before and four weeks after vaccine administration. The results indicated that the reactogenicity of the vaccine was very low. The HI antibody response differed with the age of the vaccinees, apparently being conditioned by prior exposure to the various influenza virus subtypes. The results of CF tests using strain-specific V antigens corresponded in general with HI tests, with two marked exceptions. In the youngest group nearly half of the subjects developed CF antibody to V-Swine, while all of them remained without antibody detectable in the HI test. However, when V antigen was used instead of intact virus as hemagglutinin, the post-vaccination sera of these subjects also reacted positively in the HI test. Secondly, a number of prevaccination sera from persons aged 27–50 years possessed CF antibody to A/PR 8 in the absence of homologous HI antibody. Among these subjects the antibody response to both A/PR 8 and Swine was more marked in the CF test than in the HI test. After vaccine administration most of the subjects developed antibody or responded by an antibody increase to the S antigens of both influenza A and B. No significant differences were found after intradermal (0.1 ml) and subcutaneous (0.5 ml) administration of one dose of vaccine.
Similar content being viewed by others
References
Berlin, B. S., J. L. McQueen, E. Minuse, andF. M. Davenport: A method for increasing the sensitivity of the hemagglutination-inhibition test with equine influenza virus. Virology21, 665–666 (1963).
Brandon, F. B., F. Cox, G. O. Lease, E. A. Timm, E. Quinn, andI. W. McLean: Respiratory virus vaccines. III. Some biological properties of sephadex-purified ether-extracted influenza virus antigens. J. Immunol.98, 800–805 (1967).
Davenport, F. M., A. V. Hennessy, F. B. Brandon, R. G. Webster, C. D. Barret, andO. G. Lease. Comparison of serologic and febrile responses in humans to vaccination with influenza A viruses or their hemagglutinins. L. Lab. clin. Med.63, 5–13 (1964).
Davenport, F. M., A. V. Hennessy, J. Drescher, andR. G. Webster: Analytical, serological and clinical experiences with the hemagglutinating subunits of influenza A virus. In Ciba Symposium of Cellular Biology of Myxovirus Infectious, pp. 272–287, Boston: Little, Brown and Co., 1964.
Davenport, F. M., and E.Misuse: Influenza viruses. In: Diagnostic Procedures for Viral and Rickettsial Diseases. Amer. publ. Hlth Ass. pp. 455–469 (1964).
Hennessy, A. V., andF. M. Davenport: Vaccination of infants against influenza with polyvelant influenza hemagglutinin. J. Amer. med. Ass.200, 896–898 (1967).
Hobson, D., andE. Pearson: Serological responses to Asian influenza viruses in men: a comparison of hemagglutination-inhibition and complement-fixation methods. Brit. J. exp. Path.42, 53–62 (1961).
Laver, W. G., andE. D. Kilbourne: Identification in a recombinant influenza virus of structural proteins derived from both parents. Virology30, 493–501 (1966).
Lief, F. S., andW. Henle: Antigenic analysis of influenza virus by complement fixation. VI. Implications of age distribution of antibodies to heterologous strains following infection and vaccination. J. Immunol.85, 494–510 (1960).
McDonald, J. C., andB. E. Andrews: Diagnostic methods in an influenza vaccine trial. Brit. med. J.II, 1232–1235 (1955).
Neurath, A. R., B. A. Rubin, andR. W. Hartzell: Release of neuraminidase from hemagglutinin caused by treatment of influenza virus with ether. Arch. ges. Virusforsch.28, 421–423 (1969).
Tučková, E., V. Vonka, andM. Stárek: Comparison of genetic properties of influenza viruses before and after repeated passages in monkey-kidney cell culture. Acta virol.12, 316–323 (1968).
Vonka, V.: Plaque technique with an influenza A-2 virus in rubber stoppered bottle cultures from monkey kidney cells. Arch. ges. Virusforsch.15, 514–524 (1965).
Webster, R. G., andH. G. Pereira: A common surface antigen in influenza virus from human and avian solurces. J. gen. Virol.3, 201–208 (1968).
Wiener, M., W. Henle, andG. Henle: Studies on the complement-fixation antigens of influenza viruses types A and B. J. exp. Med.83, 259–279 (1946).
Závadová, H., L. Kutinová, andV. Vonka: Preparation of antisera against the S antigen of influenza A virus by immunization of guinea pigs with internal S antigen. Arch. ges. Virusforsch.20, 421–429 (1967).
Závadová, H., V. Vonka, L. Kutinová, andE. Tučkov'a: Complete and abortive infection of cell cultures by influenza A-2 virus. J. gen. Virol.2, 341–346 (1968).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Závadová, H., Vonka, V., Adam, E. et al. Clinical reactivity and immunogenicity of hemagglutinin influenza vaccine. Archiv f Virusforschung 36, 43–52 (1972). https://doi.org/10.1007/BF01250294
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01250294